Publications by authors named "F Oberling"

Claim this Profile
R
Randomized, controlled, dose-range study of Ro 25-8315 given before and after a high-dose combination chemotherapy regimen in patients with metastatic or recurrent breast cancer patients.
P Viens, C Chabannon, P Pouillard, M Janvier, W Brugger, F Oberling

J Clin Oncol· January 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic factors in ovarian carcinoma in complete histologic remission at second-look surgery.
D. Hamid, B. Duclos, J. C. Barats, G. Prevot, M. Hummel, F. Oberling

Int J Gynecol Cancer· May 1999

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Polyethylenimine-mediated transfection of human monocytes with the IFN-gamma gene: an approach for cancer adoptive immunotherapy.
L Ringenbach, A Bohbot, P Tiberghien, F Oberling, O Feugeas

Gene Ther· November 1998

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adhesive and/or signaling functions of CD44 isoforms in human dendritic cells.
H Haegel-Kronenberger, H de la Salle, A Bohbot, F Oberling, J P Cazenave

J Immunol· October 1998

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Paclitaxel-anthracycline combination chemotherapy in relapsing advanced ovarian cancer after platinum-based chemotherapy: a pilot study.
J E Kurtz, G Deplanque, B Duclos, F Eichler, C Giron, F Oberling

Gynecol Oncol· September 1998

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis